Trials / Unknown
UnknownNCT04277767
The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease
The Combination of Ophthalmologic Tests and EEG Imaging as a New Biomarker for Alzheimer's Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Alzheimer's disease (AD) is a prevalent, long-term progressive degenerative disorder with great social impact. It is currently thought that, in addition to neurodegeneration, vascular changes also play a role in the pathophysiology of the disease. Meantime, EEG resting state has also demonstrated significant change in patients with AD in neuroscience research area. Thus, the combination of these sensitive biomarkers would lead to a potential new biomarker for detection of AD, which has higher specificity and sensitivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | observational | No intervention |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2023-02-01
- Completion
- 2023-07-01
- First posted
- 2020-02-20
- Last updated
- 2021-04-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04277767. Inclusion in this directory is not an endorsement.